Matthew Menza

6.2k total citations
75 papers, 4.3k citations indexed

About

Matthew Menza is a scholar working on Neurology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Matthew Menza has authored 75 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 26 papers in Psychiatry and Mental health and 19 papers in Cognitive Neuroscience. Recurrent topics in Matthew Menza's work include Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (21 papers) and Autism Spectrum Disorder Research (13 papers). Matthew Menza is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (21 papers) and Autism Spectrum Disorder Research (13 papers). Matthew Menza collaborates with scholars based in United States and Netherlands. Matthew Menza's co-authors include Roseanne D. Dobkin, Raymond C. Rosen, Humberto Marín, Michael A. Gara, Roger Lane, Karina Bienfait, Margery H. Mark, Lesley A. Allen, M. H. Mark and Ronald Cody and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Journal of Consulting and Clinical Psychology.

In The Last Decade

Matthew Menza

72 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Menza United States 33 2.1k 1.4k 833 809 641 75 4.3k
Bruce H. Price United States 31 1.0k 0.5× 882 0.6× 1.1k 1.3× 772 1.0× 509 0.8× 81 3.7k
Kevin J. Black United States 38 1.1k 0.5× 820 0.6× 1.2k 1.5× 1.0k 1.2× 740 1.2× 130 3.9k
Tiffany W. Chow Canada 37 1.1k 0.5× 1.8k 1.3× 1.1k 1.3× 397 0.5× 363 0.6× 95 4.3k
Veronica O’Keane Ireland 49 411 0.2× 2.2k 1.5× 567 0.7× 1.5k 1.8× 861 1.3× 147 6.8k
Marı́a J. Portella Spain 39 389 0.2× 1.4k 1.0× 923 1.1× 848 1.0× 406 0.6× 115 3.9k
Julie A. Fields United States 36 1.8k 0.9× 1.3k 0.9× 1.2k 1.4× 273 0.3× 665 1.0× 136 4.2k
K. Ranga Krishnan United States 36 333 0.2× 954 0.7× 1.4k 1.6× 414 0.5× 570 0.9× 65 3.9k
Hugh Rickards United Kingdom 40 1.4k 0.7× 1.3k 0.9× 1.2k 1.4× 1.4k 1.7× 1.4k 2.2× 124 4.1k
Sibel Tekin United States 21 1.4k 0.7× 1.7k 1.2× 1.1k 1.3× 221 0.3× 469 0.7× 35 3.8k
Matthias Lemke Germany 29 962 0.5× 998 0.7× 504 0.6× 443 0.5× 596 0.9× 82 3.0k

Countries citing papers authored by Matthew Menza

Since Specialization
Citations

This map shows the geographic impact of Matthew Menza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Menza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Menza more than expected).

Fields of papers citing papers by Matthew Menza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Menza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Menza. The network helps show where Matthew Menza may publish in the future.

Co-authorship network of co-authors of Matthew Menza

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Menza. A scholar is included among the top collaborators of Matthew Menza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Menza. Matthew Menza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobkin, Roseanne D., et al.. (2020). Telephone-based cognitive behavioral therapy for depression in Parkinson disease. Neurology. 94(16). e1764–e1773. 76 indexed citations
2.
Black, Kevin J., Henry A. Nasrallah, Stuart Isaacson, et al.. (2018). Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson’s disease psychosis: an expert consensus. CNS Spectrums. 23(6). 402–413. 9 indexed citations
3.
Dobkin, Roseanne D., Matthew Menza, Karina Bienfait, et al.. (2010). The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson’s Disease. Journal of Neuropsychiatry. 22(2). 188–195. 27 indexed citations
4.
Gandhi, Kunal K., et al.. (2010). Higher serum caffeine in smokers with schizophrenia compared to smoking controls. Drug and Alcohol Dependence. 110(1-2). 151–155. 14 indexed citations
5.
Dobkin, Roseanne D., Matthew Menza, Karina Bienfait, et al.. (2009). Ramelteon for the treatment of insomnia in menopausal women. Menopause international. 15(1). 13–18. 25 indexed citations
6.
Menza, Matthew, Roseanne D. Dobkin, Humberto Marín, et al.. (2008). A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 72(10). 886–892. 277 indexed citations
7.
Marín, Humberto, Matthew Menza, & Roseanne D. Dobkin. (2007). Parkinson's Symptoms or Depression? Look for Clinical Signs: How to Sort through Overlapping Symptoms Using DSM-IV-TR Diagnostic Criteria. Current psychiatry. 6(7). 78. 1 indexed citations
8.
Kaufman, Kenneth R., et al.. (2007). Trazodone and Ejaculatory Inhibition. Journal of Sex & Marital Therapy. 33(3). 225–230. 3 indexed citations
9.
Merrill, Jeffrey C. & Matthew Menza. (2002). Treatment of Drug Dependence in the Context of Traditional Disease Treatment Models. Psychiatric Services. 53(12). 1632–1633. 1 indexed citations
10.
Ricketts, Michael, Robert M. Hamer, J. I. Sage, et al.. (1998). Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population. Psychiatric Genetics. 8(2). 41–44. 80 indexed citations
11.
Ricketts, Michael, Robert M. Hamer, Paul Manowitz, et al.. (1998). Association of long variants of the dopamine D4 receptor exon 3 repeat polymorphism with Parkinson's disease. Clinical Genetics. 54(1). 33–38. 14 indexed citations
12.
Menza, Matthew, et al.. (1998). PSYCHIATRY IN THE GERIATRIC NEUROLOGY PRACTICE. Neurologic Clinics. 16(3). 611–633. 5 indexed citations
13.
Menza, Matthew & Raymond C. Rosen. (1995). Sleep in Parkinson's Disease. Psychosomatics. 36(3). 262–266. 61 indexed citations
14.
Menza, Matthew, et al.. (1993). Parkinson's disease and anxiety: Comorbidity with depression. Biological Psychiatry. 34(7). 465–470. 254 indexed citations
15.
Menza, Matthew, et al.. (1991). Smoking and movement disorders in psychiatric patients. Biological Psychiatry. 30(2). 109–115. 76 indexed citations
16.
Menza, Matthew, et al.. (1990). Mood changes and “on‐off” phenomena in Parkinson's disease. Movement Disorders. 5(2). 148–151. 110 indexed citations
17.
Menza, Matthew & George B. Murray. (1989). Pancreatic encephalopathy. Biological Psychiatry. 25(6). 781–784. 10 indexed citations
18.
Menza, Matthew, et al.. (1989). Benzodiazepines and catatonia: An overview. Biological Psychiatry. 26(8). 842–846. 39 indexed citations
19.
Menza, Matthew. (1988). A simple model of the interactions of dopamine, acetylcholine and GABA in movement disorders seen in psychiatry. Medical Hypotheses. 27(4). 285–288. 2 indexed citations
20.
Menza, Matthew, et al.. (1988). Treatment of anxiety associated with electrophysiologic studies.. PubMed. 17(5). 555–60. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce H. Price Breakdown of academic impact, for papers by Kevin J. Black Breakdown of academic impact, for papers by Tiffany W. Chow Breakdown of academic impact, for papers by Veronica O’Keane Breakdown of academic impact, for papers by Marı́a J. Portella Breakdown of academic impact, for papers by Julie A. Fields Breakdown of academic impact, for papers by K. Ranga Krishnan Breakdown of academic impact, for papers by Hugh Rickards Breakdown of academic impact, for papers by Sibel Tekin Breakdown of academic impact, for papers by Matthias Lemke
Rankless by CCL
2026